PREMATURE ATHEROSCLEROSIS
Clinical trials for PREMATURE ATHEROSCLEROSIS explained in plain language.
Never miss a new study
Get alerted when new PREMATURE ATHEROSCLEROSIS trials appear
Sign up with your email to follow new studies for PREMATURE ATHEROSCLEROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a simple drug combo stop heart disease before it starts?
Disease control Recruiting nowThis study will screen 1,500 people with early signs of heart disease (plaque in arteries) to see if two common drugs—rosuvastatin and colchicine—can reduce or stabilize that plaque over two years. Participants will take pills daily and get heart-healthy lifestyle advice. The goa…
Matched conditions: PREMATURE ATHEROSCLEROSIS
Phase: PHASE3 • Sponsor: Duke University • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Lupus drug may shield heart and arteries
Disease control Recruiting nowThis study tests whether anifrolumab, a drug that blocks certain immune signals, can improve blood vessel function and reduce inflammation in people with lupus. About 45 adults with lupus will receive either the drug or a placebo over 8 months. Researchers will measure changes in…
Matched conditions: PREMATURE ATHEROSCLEROSIS
Phase: PHASE2 • Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC